Author

Christophe Fraser

Primary ORCID profile (0000-0003-2399-9657 · 12 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Christophe FraseriD12 papers · University of Oxford

Biology Disciplines

Click to filter author papers

Epidemiology· 1 Evolutionary Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:statistical model· 2 Research Focus:host-pathogen & immune response· 1 Research Focus:phylogenetics / evolution· 1 Organism:virus· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Anne Cori· 1 shared Caroline ColijniD· 1 shared Geoffrey Gottlieb· 1 shared James Murphy· 1 shared Jennifer Gardy· 1 shared John Mittler· 1 shared Joshua Herbeck· 1 shared Michael Pickles· 1 shared

Activity by Year

2016-2016 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperEvolutionary Biology

Anne Cori

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genomic infectious disease epidemiology in partially sampled and ongoing outbreaks

Xavier Didelot, Christophe Fraser, Jennifer Gardy, Caroline Colijn

This paper develops a method to infer transmission trees from phylogenies in partially sampled and ongoing outbreaks by incorporating within-host genetic diversity and unsampled intermediates.

bioRxiv · Jul 22, 2016Epidemiology

Evolution of HIV virulence in response to widespread scale up of antiretroviral therapy: a modeling study

Joshua Herbeck, John Mittler, Geoffrey Gottlieb, Steve Goodreau, James Murphy, Anne Cori, Michael Pickles, Christophe Fraser

This study models how HIV virulence evolves with increased antiretroviral therapy (ART) coverage, finding that universal testing and treatment may moderately increase virulence but not pose major public health concerns.

bioRxiv · Mar 17, 2016Evolutionary Biology